These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10437628)

  • 21. The role of growth hormone in neural development.
    Scheepens A; Möderscheim TA; Gluckman PD
    Horm Res; 2005; 64 Suppl 3():66-72. PubMed ID: 16439847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRISMATIC case: bienvenidos a mi tierra de soledad: from poetry to molecular biology in southern Ecuador.
    Rosenbloom AL; Guevara-Aguirre J
    J Clin Endocrinol Metab; 1994 Sep; 79(3):695-702. PubMed ID: 7521349
    [No Abstract]   [Full Text] [Related]  

  • 23. Osteocalcin induces growth hormone/insulin-like growth factor-1 system by promoting testosterone synthesis in male mice.
    Li Y; Li K
    Horm Metab Res; 2014 Oct; 46(11):768-73. PubMed ID: 24691732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth Hormone Operates as a Neuroendocrine Regulator of Human Hair Growth Ex Vivo.
    Alam M; Below DA; Chéret J; Langan EA; Bertolini M; Jimenez F; Paus R
    J Invest Dermatol; 2019 Jul; 139(7):1593-1596. PubMed ID: 30660669
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetics and disease. Growth defect blocks cancer and diabetes.
    Leslie M
    Science; 2011 Feb; 331(6019):837. PubMed ID: 21330503
    [No Abstract]   [Full Text] [Related]  

  • 26. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function.
    Clark R
    Endocr Rev; 1997 Apr; 18(2):157-79. PubMed ID: 9101135
    [No Abstract]   [Full Text] [Related]  

  • 27. An unusual case of growth hormone receptor deficiency syndrome.
    Kwong PY; Teale JD
    Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():465-7. PubMed ID: 8888984
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin-like growth factor I messenger RNA and protein are expressed in the human lymph node and distinctly confined to subtypes of macrophages, antigen-presenting cells, lymphocytes and endothelial cells.
    Oberlin D; Fellbaum C; Eppler E
    Immunology; 2009 Nov; 128(3):342-50. PubMed ID: 20067534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin-like growth factor I in diabetes].
    Morimoto I; Kai K
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():112-6. PubMed ID: 9513399
    [No Abstract]   [Full Text] [Related]  

  • 30. Past, Present, and Future in the Relationship between Growth Retardation and the IGF System: Excerpts from the Cesar Bergada Lecture Given during the SLEP 2015 Annual Meeting.
    Jasper H
    Horm Res Paediatr; 2016; 86(5):291-299. PubMed ID: 27820935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy with recombinant human insulin-like growth factor I in children with growth hormone receptor insufficiency (Larone's syndrome)].
    Wilton P
    Probl Endokrinol (Mosk); 1994; 40(2):78-82. PubMed ID: 8197102
    [No Abstract]   [Full Text] [Related]  

  • 32. The investigation of growth hormone insensitivity.
    Savage MO; Woods KA
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):257-60. PubMed ID: 8949561
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-Sponsored Symposium.
    Rosen CJ; Conover C
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3919-22. PubMed ID: 9398687
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacological aspects of growth hormone administration.
    Laursen T
    Growth Horm IGF Res; 2004 Feb; 14(1):16-44. PubMed ID: 14700553
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased mortality associated with growth hormone treatment in critically ill adults.
    Osterziel KJ; Dietz R; Ranke MB
    N Engl J Med; 2000 Jan; 342(2):134-5; author reply 135-6. PubMed ID: 10636754
    [No Abstract]   [Full Text] [Related]  

  • 36. Ventricular expression and circulating levels of insulin-like growth factor I in heart transplant recipients.
    Ationu A; Burch M; Singer D; De Leval M; Whitehead B; Carter N
    Clin Sci (Lond); 1995 Jul; 89(1):53-7. PubMed ID: 7671568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insight into the growth hormone-insulin-like growth factor-I axis in cancer cachexia.
    Bing C
    Br J Nutr; 2005 Jun; 93(6):761-3. PubMed ID: 16022743
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: A blast from the past--insulin does it again!
    LeRoith D
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3103-4. PubMed ID: 15240577
    [No Abstract]   [Full Text] [Related]  

  • 39. A new perspective on deoxynivalenol and growth suppression.
    Voss KA
    Toxicol Sci; 2010 Feb; 113(2):281-3. PubMed ID: 19933702
    [No Abstract]   [Full Text] [Related]  

  • 40. Human pituitary growth hormone and cancer risk.
    Kalra PR; Genth-Zotz S; Coats AJ; Anker SD
    Lancet; 2002 Nov; 360(9347):1791-2. PubMed ID: 12480468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.